BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11676837)

  • 1. Hyaluronan-independent adhesion of CD44H+ and CD44v10+ lymphocytes to dermal microvascular endothelial cells and keratinocytes.
    Weimann TK; Wagner C; Funk R; Hirche H; Goos M; Wagner SN
    J Invest Dermatol; 2001 Oct; 117(4):949-57. PubMed ID: 11676837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 variant isoform v10 is expressed on tumor-infiltrating lymphocytes and mediates hyaluronan-independent heterotypic cell-cell adhesion to melanoma cells.
    Weimann TK; Wagner C; Goos M; Wagner SN
    Exp Dermatol; 2003 Apr; 12(2):204-12. PubMed ID: 12702150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration.
    Singleton PA; Bourguignon LY
    Cell Motil Cytoskeleton; 2002 Dec; 53(4):293-316. PubMed ID: 12378540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 interaction with ankyrin and IP3 receptor in lipid rafts promotes hyaluronan-mediated Ca2+ signaling leading to nitric oxide production and endothelial cell adhesion and proliferation.
    Singleton PA; Bourguignon LY
    Exp Cell Res; 2004 Apr; 295(1):102-18. PubMed ID: 15051494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial CD44H mediates adhesion of a melanoma cell line to quiescent human endothelial cells in vitro.
    Price EA; Coombe DR; Murray JC
    Int J Cancer; 1996 Feb; 65(4):513-8. PubMed ID: 8621236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44v10 expression in the mouse and functional activity in delayed type hypersensitivity.
    Rösel M; Seiter S; Zöller M
    J Cell Physiol; 1997 Jun; 171(3):305-17. PubMed ID: 9180900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion.
    Mohamadzadeh M; DeGrendele H; Arizpe H; Estess P; Siegelman M
    J Clin Invest; 1998 Jan; 101(1):97-108. PubMed ID: 9421471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique pathway in the homing of murine multiple myeloma cells: CD44v10 mediates binding to bone marrow endothelium.
    Asosingh K; Günthert U; De Raeve H; Van Riet I; Van Camp B; Vanderkerken K
    Cancer Res; 2001 Apr; 61(7):2862-5. PubMed ID: 11306459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 variant isoform CD44v10 expression of human melanoma cell lines is upregulated by hyaluronate and correlates with migration.
    Yoshinari C; Mizusawa N; Byers HR; Akasaka T
    Melanoma Res; 1999 Jun; 9(3):223-31. PubMed ID: 10465577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally active form of CD44.
    Nandi A; Estess P; Siegelman MH
    J Biol Chem; 2000 May; 275(20):14939-48. PubMed ID: 10809739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
    Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
    J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adhesion of lymphoid cells to CD44-specific substrata: the consequences of attachment depend on the ligand.
    Kim JH; Glant TT; Lesley J; Hyman R; Mikecz K
    Exp Cell Res; 2000 May; 256(2):445-53. PubMed ID: 10772817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes.
    Wagner SN; Wagner C; Reinhold U; Funk R; Zöller M; Goos M
    J Invest Dermatol; 1998 Sep; 111(3):464-71. PubMed ID: 9740242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitigation of delayed-type hypersensitivity reactions by a CD44 variant isoform v3-specific antibody: blockade of leukocyte egress.
    Seiter S; Engel P; Föhr N; Zöller M
    J Invest Dermatol; 1999 Jul; 113(1):11-21. PubMed ID: 10417612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44: structure, function, and association with the malignant process.
    Naor D; Sionov RV; Ish-Shalom D
    Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins.
    Fujisaki T; Tanaka Y; Fujii K; Mine S; Saito K; Yamada S; Yamashita U; Irimura T; Eto S
    Cancer Res; 1999 Sep; 59(17):4427-34. PubMed ID: 10485493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix.
    Henke CA; Roongta U; Mickelson DJ; Knutson JR; McCarthy JB
    J Clin Invest; 1996 Jun; 97(11):2541-52. PubMed ID: 8647947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion of multiple myeloma peripheral blood B cells to bone marrow fibroblasts: a requirement for CD44 and alpha4beta7.
    Masellis-Smith A; Belch AR; Mant MJ; Pilarski LM
    Cancer Res; 1997 Mar; 57(5):930-6. PubMed ID: 9041197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of malignant lymphoid cells to the white matter of the human central nervous system: role of different CD44 isoforms, beta 1, beta 2 and beta 7 integrins, and L-selectin.
    Aho R; Kalimo H; Salmi M; Smith D; Jalkanen S
    J Neuropathol Exp Neurol; 1997 May; 56(5):557-68. PubMed ID: 9143269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of HSV-1 infected peripheral blood mononuclear cells with cultured dermal microvascular endothelial cells: a potential model for the pathogenesis of HSV-1 induced erythema multiforme.
    Larcher C; Gasser A; Hattmannstorfer R; Obexer P; Fürhapter C; Fritsch P; Sepp N
    J Invest Dermatol; 2001 Jan; 116(1):150-6. PubMed ID: 11168811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.